If you or a loved one has been diagnosed with lung cancer, we understand the anxiety you must feel. UH Seidman Cancer Center remains at the forefront of treatment, screening and prevention of lung cancer. As part of the National Cancer Institute-designated Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine, we provide our patients with excellence in clinical care, including:
At UH Seidman Cancer Center, we treat all types of lung cancer, including small cell and non-small cell lung cancers, from early to advanced stages of progression.
At UH Seidman Cancer Center, each patient is the center of a compassionate, highly trained team. Our tumor board review, led by a multidisciplinary team, evaluates every single patient case. We have the resources of an entire team of national experts that collaborates to guide all cancer care decisions. Our team includes:
Our pulmonologists and thoracic surgeons have advanced training in minimally invasive techniques for lung nodules biopsy. They employ navigation bronchoscopy, a technique using GPS technology to navigate to lesions that cannot be seen with the eye. Endobronchial ultrasound can be used to biopsy lymph nodes outside the bronchus.
At UH Seidman Cancer Center, every one of our thoracic surgeons is skilled in minimally invasive techniques. Nearly 75 percent of our complex lung cancer surgeries are performed minimally invasively. This percentage is among the highest in the nation. Due to our low rate of complications and advanced care, our length of stay is shorter than the national average.
Our history of leadership in cancer research includes extensive lung cancer studies. For example, our clinical researchers discovered a mutation that predicted patient response to targeted therapy. A University Hospitals physician co-chaired the largest national study used to prove the value of targeted therapy to treat lung cancer. It was the first lung cancer breakthrough in over a decade.
Our clinical researchers also discovered a promising, novel biomarker to predict the survival of patients with advanced lung cancer. Recently, UH Seidman Cancer Center physicians reported on a long-term study of lung cancer patients confirming the importance of ongoing surveillance.
UH Seidman Cancer Center is a nationally recognized cancer program with expertise for both routine and very complex cancer care, including advanced stage III and IV cancer.
UH Seidman Cancer Center has many available clinical trials for patients with lung cancer, including:
Request an appointment with a specialist at University Hospitals.
or use our
Online Request Form
Click here for Patient Referrals
Click here for directions
For general information:
216-844-8447 or 888-844-8447
Contact Us Online